Sometimes success can be measured in more ways than in dollar amounts. Serial entrepreneur Eric Lefkovsky experienced wild success as the CEO of the ever popular website, Groupon, with the company being worth over $1 billion only 16 months after it began. After also introducing Lightbank, an investment organization that provides guidance and funding for groundbreaking technology companies, he realized that monetary success did not have to be his only goal in life. Blessed with more wealth than he could ever need in a lifetime, Lefkovsky used his knowledge for the greater good of humanity.
After a loved one of Lefkovsky’s went through the grueling experience of cancer treatment, Lefkovsky realized just how many gaps there are in our healthcare system when it comes to treating patients. He soon discovered that even the most esteemed treatment centers were not sharing their patients’ data. Treatment options therefore were more generalized based on patients’ type of cancer rather than individual circumstance. Eric Lefkovsky created Tempus Labs in response, which aimed to gather an enormous database of information regarding different types of tumors and cancers and comparing them with patients’ individual DNA. Tempus gives physicians the tools to analyze and edit each individual patient’s data and treatment plan. Tempus has recently partnered up with CancerLinQ, a non-profit heath information platform.
Eric and Liz Lefkovsky also founded the Lefkovsky Family Foundation, which supports many other organizations that do work to better their communities. This foundation donated over $1 million to the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago to help further research of oncology treatments. The Lefkovsky family foundation also provided a grant that would give free admission to all youth who visit Chicago’s Museum of Contemporary Art. The lefkovskys are among the group of the world’s billionaires who have made the pledge through the Bill Gates/Warren Buffet initiative to share at least half of their wealth with other people in need and important causes around the world. They believe that this is their greatest lifetime accomplishment.
Dr. David Samadi was born and raised in a Persian Jewish community in Iran. In 1979 after the Iranian Revolution, he was forced to move to Belgium with his brother at the age of 15. The Revolution separated him with his family and had to start a new life together with his brother Dan. Despite the fact that they were young and separated from their parents and little sister, Samadi and Dan worked hard and wanted to make their parents proud of them. They studied hard and were determined to achieve their dreams. Dr. Samadi wanted to become a doctor and he worked hard to ensure that he had accomplished that dream. After arriving at the U.S, their lives became even better and their future appeared brighter.
When he arrived in Belgium, Samadi was determined to pursue his dream of becoming a doctor and therefore he immediately enrolled for studies. After arriving in the United States, he joined Roselyn, New York to complete his high school education. After finishing high school, Samadi went to Stony Brook University where he obtained his degree in biochemistry through a full scholarship program. In 1994 he joined Stony Brook School of Medicine for his master’s degree. Dr. Samadi went to Montefiore Medical Center in 200 where finished his postgraduate training in Urology.
Dr. Samadi also went to France and through the help of Professor Claude Abbou, he accomplished a robotic radical prostatectomy fellowship at Henri Mondor Hospital in France. Samadi also joined the department of Mt. Sinai School in 2007 and became the Vice-chairperson of the Department of Urology. To know more about him click here.
Dr. David Samadi is also an innovator. He came up with a prostate cancer treatment method also known as Samadi Modern Advanced Robotic Technique (SMART) which has been proven to be more effective for cancer treatment. The method has fewer side effects compared to other conventional cancer treatment methods and is less painful.
Dr. David Samadi is the current Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital. He has served in that position since June 6, 2013. Samadi is a leader in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. He has permed more than 8000 Laparoscopic procedures since he began his practice. Besides his busy profession, Dr. Samdi also hosts a show, Dr. David Samadi TV where he shares his medical experience with the public and answers various questions regarding robotic surgery.